Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients
Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study i...
Saved in:
Published in | Eye (London) Vol. 36; no. 10; pp. 2062 - 2066 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.10.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.
Methods
The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.
Results
The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (
p
< 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (
p
< 0.001 for both).
Conclusion
The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future. |
---|---|
AbstractList | BackgroundThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.MethodsThe study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.ResultsThe mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).ConclusionThe low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future. The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.BACKGROUNDThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.METHODSThe study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074-0.078)U/L, 0.002 (0.001-0.006) mmol/ml, 1.56 (1.51-1.62)U/L and 1.69 (1.65-1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013-0.037)U/L, 0.029 (0.018-0.049) mmol/ml, 4.13 (4.01-4.17) U/L and 0.74 (0.65-0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).RESULTSThe mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074-0.078)U/L, 0.002 (0.001-0.006) mmol/ml, 1.56 (1.51-1.62)U/L and 1.69 (1.65-1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013-0.037)U/L, 0.029 (0.018-0.049) mmol/ml, 4.13 (4.01-4.17) U/L and 0.74 (0.65-0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.CONCLUSIONThe low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future. Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared. Results The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group ( p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher ( p < 0.001 for both). Conclusion The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future. |
Author | Seven, Erbil Tekin, Serek |
Author_xml | – sequence: 1 givenname: Serek orcidid: 0000-0002-6660-8313 surname: Tekin fullname: Tekin, Serek email: drserektekin091@gmail.com organization: Department of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University – sequence: 2 givenname: Erbil orcidid: 0000-0001-5629-291X surname: Seven fullname: Seven, Erbil organization: Department of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University |
BookMark | eNp9kctuFDEQRS0URCaBH2BliQ2LNPjZ3d4gRREvKRIbkNhZbnfNjIPbHlzdI_IJ_DXOTBAii6xqUedW1b11Rk5STkDIS87ecCb7t6i4krJhgjeMd1o2_AlZcdW1jVZanZAVM5o1Qojvp-QM8Yax2uzYM3IqlWqF7tmK_L5EBMQJ0kzzmiKUZaLezS46hAtaYFw8jHQTl9nN21APuKAujRSXHZT8K4xAx4BT7SJQ5-ewD3MAPDCTizmNwcURtrcVjLCHiDQk-gOKm7PPaUG6c1WQZnxOnq5dRHhxX8_Jtw_vv159aq6_fPx8dXndeKX53PTGeG2EW3vOWmaG0fsOusE7LaTsx34NbOA9dM5U97yt4UBneqeGodNGai3Pybvj3N0yTDD6uru4aHclTK7c2uyC_b-TwtZu8t4aZYxpZR3w-n5AyT8XwNlOAT3E6BLkBa3Qbd3Y6QP66gF6k5eSqj0rOl4xoSSvVH-kfMmIBdbWh5p2DbvuD9FyZu_-bY__ttWSPfzb3knFA-lfH4-K5FGEFU4bKP-uekT1ByTXwdU |
CitedBy_id | crossref_primary_10_1016_j_jff_2025_106743 crossref_primary_10_1007_s13530_023_00183_8 crossref_primary_10_58854_jicm_1412375 crossref_primary_10_2147_IJGM_S375282 crossref_primary_10_1021_acsomega_2c05989 crossref_primary_10_3103_S0095452724050086 crossref_primary_10_3390_pharmaceutics14081582 crossref_primary_10_1016_j_tiv_2025_106037 crossref_primary_10_1007_s11356_022_24920_7 crossref_primary_10_1080_17469899_2024_2368801 crossref_primary_10_2478_acve_2024_0025 crossref_primary_10_3390_biomedicines11020292 crossref_primary_10_3389_fphar_2023_1235810 crossref_primary_10_1016_j_prmcm_2024_100399 crossref_primary_10_3390_ph17030381 crossref_primary_10_3390_ijms23031255 crossref_primary_10_3390_nu14040913 crossref_primary_10_1167_tvst_11_12_16 |
Cites_doi | 10.1016/j.mehy.2015.02.017 10.1016/j.clae.2007.03.001 10.1167/iovs.04-1395 10.1167/iovs.11-7732 10.3389/fphar.2015.00098 10.1038/srep04608 10.1016/j.exer.2019.107897 10.1016/S0076-6879(84)05016-3 10.1155/2016/3164734 10.1038/eye.2013.262 10.1093/clinchem/34.3.497 10.3109/02713688709025227 10.1097/ICO.0000000000001018 10.1016/0891-5849(91)90192-6 10.1177/002215540205000306 10.3892/ol.2012.931 10.1016/j.mito.2017.05.009 10.1167/iovs.05-0828 10.1167/iovs.04-0549 10.3928/1081597X-20090401-07 10.4103/jovr.jovr_80_18 10.1016/S0891-5849(98)00095-1 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021 The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021. 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists. |
Copyright_xml | – notice: The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021 – notice: The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021. – notice: 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists. |
DBID | AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/s41433-021-01753-1 |
DatabaseName | CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-5454 |
EndPage | 2066 |
ExternalDocumentID | PMC9499963 10_1038_s41433_021_01753_1 |
GroupedDBID | --- -Q- .GJ 0R~ 29G 2WC 36B 39C 3O- 4.4 406 53G 5RE 6PF 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFFNX AFHIU AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ATHPR AXYYD AYFIA BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP E3Z EBLON EBS EBX EE. EIOEI EJD EMB EMOBN F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 L7B M1P M7P NQJWS O9- OK1 P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI ZXP AAYXX CITATION 3V. 7TK 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PKEHL PQEST PQUKI PRINS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c451t-899c592afc10609bdcc7e7bca52338d8fe0b18e7a909516021e798a4bb7593553 |
IEDL.DBID | 7X7 |
ISSN | 0950-222X 1476-5454 |
IngestDate | Thu Aug 28 05:03:03 EDT 2025 Fri Jul 11 12:45:03 EDT 2025 Sat Aug 23 14:59:39 EDT 2025 Tue Jul 01 03:00:37 EDT 2025 Thu Apr 24 23:02:29 EDT 2025 Mon Jul 21 06:08:36 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-899c592afc10609bdcc7e7bca52338d8fe0b18e7a909516021e798a4bb7593553 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6660-8313 0000-0001-5629-291X |
OpenAccessLink | https://www.nature.com/articles/s41433-021-01753-1.pdf |
PMID | 34462580 |
PQID | 2716792431 |
PQPubID | 33647 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9499963 proquest_miscellaneous_2567987563 proquest_journals_2716792431 crossref_citationtrail_10_1038_s41433_021_01753_1 crossref_primary_10_1038_s41433_021_01753_1 springer_journals_10_1038_s41433_021_01753_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-10-01 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationSubtitle | The Scientific Journal of The Royal College of Ophthalmologists |
PublicationTitle | Eye (London) |
PublicationTitleAbbrev | Eye |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Beutler (CR11) 1963; 61 Behndig, Karlsson, Johansson, Brannstrom, Marklund (CR23) 2001; 42 Zhou, Sawaguchi, Twining, Sugar, Feder, Yue (CR16) 1998; 39 Pompella, Corti (CR20) 2015; 6 Arnal, Peris-Martínez, Menezo (CR3) 2011; 52 Karamichos, Hutcheon, Rich, Trinkaus-randall, Asara, Zieske (CR22) 2014; 4 Buddi, Lin, Atilano, Zorapapel, Kenney, Brown (CR4) 2002; 50 Balmus, Alexa, Ciuntu, Danielescu, Stoica, Cojocaru (CR24) 2020; 190 Dudakova, Liskova, Jirsova (CR15) 2015; 84 Nita, Grzybowski (CR1) 2016; 2016 Balasubramanian, Mohan, Pye, Willcox (CR17) 2012; 90 Atalla, Fernandez, Rao (CR18) 1987; 6 Kılıç, Bayraktar, Bayraktar, Kurt, Kavutçu (CR26) 2016; 35 Krumeich, Kezirian (CR9) 2009; 25 Esterbauer, Schaur, Zollner (CR27) 1991; 11 Aebi (CR10) 1984; 105 Chwa, Atilano, Reddy, Jordan, Kim, Kenney (CR14) 2006; 47 Kenney, Chwa, Atilano, Tran, Carballo, Saghizadeh (CR6) 2005; 46 Cantemir, Iuliana Alexa, Ciobica, Miruna Balmus, Antioch, Stoica (CR25) 2016; 67 Wagner, Barr, Zadnik (CR8) 2007; 30 Sun, Oberley, Li (CR12) 1988; 34 Atilano, Coskun, Chwa, Jordan, Reddy, Le (CR13) 2005; 46 Toprak, Kucukatay, Yildirim, Kilic-Toprak, Erkek (CR19) 2014; 28 Squadrito, Pryor (CR5) 1998; 25 Vallabh, Romano, Willoughby (CR2) 2017; 36 Atilano, Lee, Fukuhara, Chwa, Nesburn, Udar (CR7) 2019; 14 Zitka, Skalickova, Gumulec, Masarik, Adam, Hubalek (CR21) 2012; 4 A Cantemir (1753_CR25) 2016; 67 I Balmus (1753_CR24) 2020; 190 E Beutler (1753_CR11) 1963; 61 E Arnal (1753_CR3) 2011; 52 O Zitka (1753_CR21) 2012; 4 A Pompella (1753_CR20) 2015; 6 H Wagner (1753_CR8) 2007; 30 S Balasubramanian (1753_CR17) 2012; 90 M Nita (1753_CR1) 2016; 2016 L Atalla (1753_CR18) 1987; 6 Y Sun (1753_CR12) 1988; 34 H Aebi (1753_CR10) 1984; 105 R Kılıç (1753_CR26) 2016; 35 M Kenney (1753_CR6) 2005; 46 H Esterbauer (1753_CR27) 1991; 11 S Atilano (1753_CR13) 2005; 46 I Toprak (1753_CR19) 2014; 28 D Karamichos (1753_CR22) 2014; 4 R Buddi (1753_CR4) 2002; 50 J Krumeich (1753_CR9) 2009; 25 A Behndig (1753_CR23) 2001; 42 L Zhou (1753_CR16) 1998; 39 N Vallabh (1753_CR2) 2017; 36 M Chwa (1753_CR14) 2006; 47 L Dudakova (1753_CR15) 2015; 84 S Atilano (1753_CR7) 2019; 14 G Squadrito (1753_CR5) 1998; 25 |
References_xml | – volume: 84 start-page: 518 year: 2015 end-page: 24 ident: CR15 article-title: Is copper imbalance an environmental factor influencing keratoconus development? publication-title: Med Hypotheses doi: 10.1016/j.mehy.2015.02.017 – volume: 30 start-page: 223 year: 2007 end-page: 32 ident: CR8 article-title: Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date publication-title: Cont Lens Anterior Eye doi: 10.1016/j.clae.2007.03.001 – volume: 46 start-page: 1256 year: 2005 end-page: 63 ident: CR13 article-title: Accumulation of mitochondrial DNA damage in keratoconus corneas publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1395 – volume: 67 start-page: 1538 year: 2016 end-page: 41 ident: CR25 article-title: Evaluation of antioxidant enzymes in keratoconus publication-title: Rev Chim – volume: 52 start-page: 8592 year: 2011 end-page: 7 ident: CR3 article-title: Oxidative stress in keratoconus? publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7732 – volume: 6 start-page: 98 year: 2015 ident: CR20 article-title: The changing faces of glutathione, a cellular protagonist publication-title: Front Pharmacol doi: 10.3389/fphar.2015.00098 – volume: 4 year: 2014 ident: CR22 article-title: In vitro model suggests oxidative stress involved in keratoconus disease publication-title: Sci Rep. doi: 10.1038/srep04608 – volume: 190 start-page: 107897 year: 2020 ident: CR24 article-title: Oxidative stress markers dynamics in keratoconus patients’ tears before and after corneal collagen crosslinking procedure publication-title: Exp Eye Res doi: 10.1016/j.exer.2019.107897 – volume: 105 start-page: 121 year: 1984 end-page: 6 ident: CR10 article-title: Catalase in vitro publication-title: Methods Enzymol doi: 10.1016/S0076-6879(84)05016-3 – volume: 2016 start-page: 3164734 year: 2016 ident: CR1 article-title: The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior publication-title: Oxid Med Cell Longev doi: 10.1155/2016/3164734 – volume: 28 start-page: 285 year: 2014 ident: CR19 article-title: Increased systemic oxidative stress in patients with keratoconus publication-title: Eye doi: 10.1038/eye.2013.262 – volume: 34 start-page: 497 year: 1988 end-page: 500 ident: CR12 article-title: A simple method for clinical assay of superoxide dismutase publication-title: Clin Chem doi: 10.1093/clinchem/34.3.497 – volume: 6 start-page: 1181 year: 1987 end-page: 7 ident: CR18 article-title: Immunohistochemical localization of catalase in ocular tissue publication-title: Curr Eye Res doi: 10.3109/02713688709025227 – volume: 35 start-page: 1512 year: 2016 end-page: 5 ident: CR26 article-title: Evaluation of serum superoxide dismutase activity, malondialdehyde, and zinc and copper levels in patients with keratoconus publication-title: Cornea doi: 10.1097/ICO.0000000000001018 – volume: 11 start-page: 81 year: 1991 end-page: 128 ident: CR27 article-title: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes publication-title: Free Radic Biol Med doi: 10.1016/0891-5849(91)90192-6 – volume: 50 start-page: 341 year: 2002 end-page: 51 ident: CR4 article-title: Evidence of oxidative stress in human corneal diseases publication-title: J Histochem Cytochem doi: 10.1177/002215540205000306 – volume: 39 start-page: 1117 year: 1998 end-page: 24 ident: CR16 article-title: Expression of degradative enzymes and protease inhibitors in corneas with keratoconus publication-title: Invest Ophthalmol Vis Sci – volume: 4 start-page: 1247 issue: Dec year: 2012 end-page: 53 ident: CR21 article-title: Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients publication-title: Oncol Lett doi: 10.3892/ol.2012.931 – volume: 36 start-page: 103 year: 2017 end-page: 13 ident: CR2 article-title: Mitochondrial dysfunction and oxidative stress in corneal disease publication-title: Mitochondrion doi: 10.1016/j.mito.2017.05.009 – volume: 47 start-page: 1902 year: 2006 end-page: 10 ident: CR14 article-title: Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0828 – volume: 46 start-page: 823 year: 2005 end-page: 32 ident: CR6 article-title: Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-0549 – volume: 25 start-page: 357 year: 2009 end-page: 65 ident: CR9 article-title: Circular keratotomy to reduce astigmatism and improve vision in stage I and II keratoconus publication-title: j Refract Surg doi: 10.3928/1081597X-20090401-07 – volume: 42 start-page: 2293 year: 2001 end-page: 6 ident: CR23 article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea publication-title: Invest Ophthalmol Vis Sci – volume: 90 start-page: 45 issue: Jun year: 2012 ident: CR17 article-title: Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus publication-title: Acta Ophthalmol – volume: 14 start-page: 62 year: 2019 ident: CR7 article-title: Corneal oxidative damage in keratoconus cells due to decreased oxidant elimination from modified expression levels of SOD enzymes, PRDX6, SCARA3 publication-title: J Ophthalmic Vis Res doi: 10.4103/jovr.jovr_80_18 – volume: 61 start-page: 882 year: 1963 end-page: 8 ident: CR11 article-title: Improved method for the determination of blood glutathione publication-title: J Lab Clin Med – volume: 25 start-page: 392 year: 1998 end-page: 403 ident: CR5 article-title: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(98)00095-1 – volume: 42 start-page: 2293 year: 2001 ident: 1753_CR23 publication-title: Invest Ophthalmol Vis Sci – volume: 35 start-page: 1512 year: 2016 ident: 1753_CR26 publication-title: Cornea doi: 10.1097/ICO.0000000000001018 – volume: 61 start-page: 882 year: 1963 ident: 1753_CR11 publication-title: J Lab Clin Med – volume: 6 start-page: 98 year: 2015 ident: 1753_CR20 publication-title: Front Pharmacol doi: 10.3389/fphar.2015.00098 – volume: 34 start-page: 497 year: 1988 ident: 1753_CR12 publication-title: Clin Chem doi: 10.1093/clinchem/34.3.497 – volume: 14 start-page: 62 year: 2019 ident: 1753_CR7 publication-title: J Ophthalmic Vis Res doi: 10.4103/jovr.jovr_80_18 – volume: 46 start-page: 823 year: 2005 ident: 1753_CR6 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-0549 – volume: 36 start-page: 103 year: 2017 ident: 1753_CR2 publication-title: Mitochondrion doi: 10.1016/j.mito.2017.05.009 – volume: 6 start-page: 1181 year: 1987 ident: 1753_CR18 publication-title: Curr Eye Res doi: 10.3109/02713688709025227 – volume: 105 start-page: 121 year: 1984 ident: 1753_CR10 publication-title: Methods Enzymol doi: 10.1016/S0076-6879(84)05016-3 – volume: 39 start-page: 1117 year: 1998 ident: 1753_CR16 publication-title: Invest Ophthalmol Vis Sci – volume: 67 start-page: 1538 year: 2016 ident: 1753_CR25 publication-title: Rev Chim – volume: 25 start-page: 392 year: 1998 ident: 1753_CR5 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(98)00095-1 – volume: 90 start-page: 45 issue: Jun year: 2012 ident: 1753_CR17 publication-title: Acta Ophthalmol – volume: 4 start-page: 1247 issue: Dec year: 2012 ident: 1753_CR21 publication-title: Oncol Lett doi: 10.3892/ol.2012.931 – volume: 47 start-page: 1902 year: 2006 ident: 1753_CR14 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0828 – volume: 11 start-page: 81 year: 1991 ident: 1753_CR27 publication-title: Free Radic Biol Med doi: 10.1016/0891-5849(91)90192-6 – volume: 50 start-page: 341 year: 2002 ident: 1753_CR4 publication-title: J Histochem Cytochem doi: 10.1177/002215540205000306 – volume: 4 year: 2014 ident: 1753_CR22 publication-title: Sci Rep. doi: 10.1038/srep04608 – volume: 25 start-page: 357 year: 2009 ident: 1753_CR9 publication-title: j Refract Surg doi: 10.3928/1081597X-20090401-07 – volume: 84 start-page: 518 year: 2015 ident: 1753_CR15 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2015.02.017 – volume: 190 start-page: 107897 year: 2020 ident: 1753_CR24 publication-title: Exp Eye Res doi: 10.1016/j.exer.2019.107897 – volume: 28 start-page: 285 year: 2014 ident: 1753_CR19 publication-title: Eye doi: 10.1038/eye.2013.262 – volume: 46 start-page: 1256 year: 2005 ident: 1753_CR13 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1395 – volume: 30 start-page: 223 year: 2007 ident: 1753_CR8 publication-title: Cont Lens Anterior Eye doi: 10.1016/j.clae.2007.03.001 – volume: 2016 start-page: 3164734 year: 2016 ident: 1753_CR1 publication-title: Oxid Med Cell Longev doi: 10.1155/2016/3164734 – volume: 52 start-page: 8592 year: 2011 ident: 1753_CR3 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7732 |
SSID | ssj0014770 |
Score | 2.4684734 |
Snippet | Background
The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced... BackgroundThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced... The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione... |
SourceID | pubmedcentral proquest crossref springer |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 2062 |
SubjectTerms | 692/308/53/2423 692/53/2423 692/699/3161/3163 Antioxidants Catalase Glutathione Keratoconus Laboratory Medicine Malondialdehyde Medicine Medicine & Public Health Ophthalmology Oxidative stress Patients Pharmaceutical Sciences/Technology Superoxide dismutase Surgery Surgical Oncology Therapeutic targets |
Title | Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients |
URI | https://link.springer.com/article/10.1038/s41433-021-01753-1 https://www.proquest.com/docview/2716792431 https://www.proquest.com/docview/2567987563 https://pubmed.ncbi.nlm.nih.gov/PMC9499963 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FsZeRtttLFtbVNjbaupfsuSnkpSGUmgYY4W8GVlS1tDE7up4rH9C_-veKYpDCu2LDbaMhO_su9N39x3Ad9QDw22WYmwi8RCrMFCxDAODtt2ElKSjCNG9GmUX1-nlmI_9hlvj0ypX_0T3oza1pj3yk1gQYBCjvTu9-xtQ1yhCV30LjbewTdRllNIlxl3AFaXCNYtDLyIM0A6OfdFMmMiTJkVHgRBMCqbRZQ-iTcO09jaf50o-A0ydHRruwAfvQLL-UuK78MZWe_DuykPkH-Gx33FtsnrCUMPaOXObNGivjtk9UbVaw_6gxlHiYV3hRVUZ1rREGf5_aiwz02ZOqdqWUdXDP8e56sbM1ayuqNLE2JsHHDijjKOGTSt2S9zMNcbWbcM8VWvzCa6H57_PLgLfbyHQKY8WAYZemuexmmiME8O8NFoLK0qtMFhNpJETG5aRtELl5Jdl-O6syKVKy1JwomlPPsNWhcv-Akwnpc24inNuqNieK2niUqaRSlIlJ4ntQbR62YX2ZOTUE2NWOFA8kcVSQAVOUjgBFVEPfnTP3C2pOF4dvb-SYeE_y6ZYK1EPjrrb-EERSqIqW7c4hhMwJXiW9EBsyL6blSi5N-9U0xtHzZ27ABKfPF5pyXryl9f69fW1foP3MRVduBTCfdha3Lf2AF2hRXno9P0QtvvDwWCE58H56OevJ4luCow |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NTgJeEH9FYYCR4IlFS5w4cR4QGrCpY2uF0Cb1LTi2yyraZCwNsI_Al-EzcucmqTqJve0lD40dW72L7365u98BvEI9MMLGEWITiReufE9x6XsGbbvxKUlHUUR3OIoHJ9GnsRhvwN-2FobSKtsz0R3UptT0jXyHJxQw4Gjv3p398KhrFEVX2xYaS7U4tBe_ELJVbw8-onxfc76_d_xh4DVdBTwdiWDhIcDQIuVqohEN-WlutE5skmuFkCyURk6snwfSJiol7yNGG2iTVKoozxNBZOQhPvcGbEYhQpkebL7fG33-0sUtosS1p8OZvoeWd9yU6fih3KkidE0oZkrwHUGCF6ybwpV_ezk781KI1lm-_btwp3FZ2e5Sx-7Bhi3uw81hE5R_AH92O3ZPVk4Y6nQ9Z-6zEFrIbXZO5LDWsG-o45TqWBb4oyoMq2oiKf89NZaZaTWn5HDLqM7ip2N5dWPmalYWVNti7OkFDpxRjlPFpgX7TmzQJaL5umINOWz1EE6uRRaPoFfgth8D02FuY6F4KgyV9wslDc9lFKgwUnIS2j4E7Z-d6Yb-nLpwzDIXhg9lthRQhotkTkBZ0Ic33ZyzJfnHlaO3WhlmzUFQZSu17cPL7ja-whSXUYUtaxwjKBSWiDjsQ7Im-25VIgFfv1NMTx0ZeOogK87cbrVktfj_9_rk6r2-gFuD4-FRdnQwOnwKtzmVfLgExi3oLc5r-wwdsUX-vNF-Bl-v-4X7B6l0RN8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NIU28IP6KwgZGgicWNXHi2HlA08SoNsYmHpjUt-DEzlbRJmNpgH2EfaV9Ou7cJFUnsbe99KGxa6t39t0vd_c7gHeoB0bYOEJsovCDa9_TXPmeQdtufErS0RTRPTqO90-iL2MxXoPrrhaG0iq7O9Fd1KbK6R35kEsKGHC0d8OiTYv4tjfaOf_lUQcpirR27TQWKnJoL_8gfKs_HuyhrN9zPvr8_dO-13YY8PJIBHMPwUYuEq6LHJGRn2Qmz6WVWa4RnoXKqML6WaCs1Al5IjHaQysTpaMsk4KIyUP83XtwX4YioDMmxz3YCyLpGtXhPN9DGzxuC3b8UA3rCJ0Uip4SkEe44AWrRnHp6d7M07wRrHU2cPQIHrbOK9tdaNtjWLPlE9g4asPzT-Fqt-f5ZFXBULubGXMviNBWbrMLoom1hp2itlPSY1Xil7o0rG6IrvzvxFhmJvWM0sQto4qL347v1Y2Z6WlVUpWLsWeXOHBK2U41m5TsJ_FCV4jrm5q1NLH1Mzi5E0k8h_USt_0CWB5mNhaaJ8JQob_QyvBMRYEOI62K0A4g6P7sNG-J0KkfxzR1AflQpQsBpbhI6gSUBgP40M85X9CA3Dp6s5Nh2l4JdbpU4AG87R_jYaYIjS5t1eAYQUExKeJwAHJF9v2qRAe--qScnDla8MSBV5y53WnJcvH_7_Xl7Xt9Axt4zNKvB8eHr-ABp9oPl8m4Cevzi8ZuoUc2z1471Wfw467P2j8xwkev |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+serum+catalase%2C+reduced+glutathione%2C+and+superoxide+dismutase+activities+and+malondialdehyde+levels+in+keratoconus+patients&rft.jtitle=Eye+%28London%29&rft.au=Tekin%2C+Serek&rft.au=Seven%2C+Erbil&rft.date=2022-10-01&rft.pub=Nature+Publishing+Group&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=36&rft.issue=10&rft.spage=2062&rft.epage=2066&rft_id=info:doi/10.1038%2Fs41433-021-01753-1&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon |